Stockscreener 앱 받기
217.12
1.56%
-3.45
시간 외 거래:
217.12
전일 마감가:
$220.57
열려 있는:
$219.25
하루 거래량:
762.21K
Relative Volume:
1.13
시가총액:
$19.08B
수익:
$12.71B
순이익/손실:
$435.50M
주가수익비율:
42.16
EPS:
5.15
순현금흐름:
$843.20M
1주 성능:
-0.68%
1개월 성능:
-9.70%
6개월 성능:
+0.93%
1년 성능:
+8.58%
1일 변동 폭
$216.92
$220.41
1주일 범위
$213.10
$229.50
52주 변동 폭
$191.97
$258.59
래버러토리 코퍼레이션 Stock (LH) Company Profile
명칭
Labcorp Holdings Inc
전화
(336) 229-1127
주소
358 S MAIN ST, BURLINGTON, NC
LH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
217.12 | 19.08B | 12.71B | 435.50M | 843.20M | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
427.50 | 169.62B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
186.83 | 138.06B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
411.49 | 32.79B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
102.48 | 29.99B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
143.91 | 26.61B | 15.41B | 1.37B | 2.11B | 7.50 |
래버러토리 코퍼레이션 Stock (LH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-02 | 개시 | Redburn Atlantic | Buy |
| 2025-03-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-01-07 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2024-12-10 | 재개 | Jefferies | Buy |
| 2024-10-30 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-10-01 | 개시 | Piper Sandler | Neutral |
| 2024-03-25 | 업그레이드 | Argus | Hold → Buy |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-02-09 | 개시 | Evercore ISI | In-line |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-09-06 | 개시 | HSBC Securities | Hold |
| 2022-12-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-09-19 | 다운그레이드 | Argus | Buy → Hold |
| 2022-08-22 | 재개 | Morgan Stanley | Overweight |
| 2022-01-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-01-11 | 업그레이드 | Argus | Hold → Buy |
| 2021-01-11 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-07-13 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | 재개 | Deutsche Bank | Buy |
| 2020-05-15 | 업그레이드 | Mizuho | Neutral → Buy |
| 2020-04-29 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-04-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2019-07-16 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2019-04-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-01-17 | 개시 | UBS | Buy |
| 2019-01-03 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2018-10-30 | 다운그레이드 | Argus | Buy → Hold |
| 2018-10-25 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | 재개 | BofA/Merrill | Buy |
| 2018-06-07 | 업그레이드 | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | 개시 | Argus | Buy |
모두보기
래버러토리 코퍼레이션 주식(LH)의 최신 뉴스
Drug Screening Market Size Worth USD 10.34 Billion by 2034 | CAGR of 4.84% from 2025 to 2034 - GlobeNewswire Inc.
Labcorp Holdings: Regaining Credibility - Seeking Alpha
Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Labcorp Q1 Earnings Preview: Diagnostics Arm Likely to Drive Growth - Nasdaq
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S. - MarketScreener
Labcorp Holdings (NYSE:LH) Has Announced A Dividend Of $0.72 - simplywall.st
Truist Adjusts Labcorp (LH) Price Target Ahead of Q1 Results | L - GuruFocus
Labcorp Declares Quarterly Dividend - Eastern Progress
What You Need to Know Ahead of Labcorp Holdings' Earnings Release - MSN
Truist Securities Lowers Labcorp Price Target to $274 From $285, Maintains Buy Rating - MarketScreener
Baird Adjusts Price Target on Labcorp Holdings to $253 From $292, Keeps Outperform Rating - MarketScreener
What You Need To Know Ahead Of Labcorp Holdings' Earnings Release - Barchart.com
Labcorp Holdings Inc. (LH) Declares Cash Dividend for Shareholders - GuruFocus
Labcorp (LH) Maintains Quarterly Dividend, Offers 1.25% Yield - GuruFocus
Labcorp Declares Quarterly Dividend | LH Stock News - GuruFocus
Labcorp Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Barclays Adjusts Labcorp Holdings' Price Target to $240 From $260 - MarketScreener
Labcorp Keeps Quarterly Dividend at $0.72 a Share, Payable June 11 to Shareholders of Record as of May 29 - MarketScreener
Labcorp Holdings Declares Cash Dividend for Shareholders - TipRanks
Full Fed. Circ. Lets Stand Patent Tied To $400M Labcorp Loss - Law360
Evercore ISI Adjusts Price Target on Labcorp Holdings to $260 From $275, Maintains Outperform Rating - MarketScreener
Is it the Right Time to Retain Labcorp Stock in Your Portfolio? - Yahoo Finance
Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.
Labcorp launches blood test to accelerate Alzheimer’s diagnosis - Yahoo Finance
Here's Why Labcorp (LH) is a Strong Growth Stock - Yahoo Finance
Assessing Labcorp Hldgs: Insights From 8 Financial Analysts - Benzinga
Labcorp Launches New Blood Test to Diagnose Alzheimer's Disease - MarketScreener
LH Stock to Gain From Launch of HPV and STI Self-Collection Options - TradingView
Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease - Financial Times
Redburn Atlantic Initiates Labcorp Holdings at Buy With $276 Price Target - MarketScreener
Esoteric Testing Market Deep Research 2025-2032 | LabCorp, Quest Diagnostics, OPKO Health, Miraca Holdings - openPR.com
Game-Changing Alzheimer's Blood Test Achieves 95% Accuracy, Revolutionizing Diagnosis - Stock Titan
Labcorp Launches First-Of-Its-Kind Immunoassay To Accelerate Path To Diagnosis Of Alzheimer's Disease - MarketScreener
Labcorp Holdings (NYSE:LH) Introduces FDA-Approved Self-Collection Tests For HPV And STIs - simplywall.st
Labcorp to Announce First Quarter Financial Results on April 29, 2025 - Eastern Progress
Labcorp to offer HPV and STI self-collection solutions - TipRanks
Game-Changing HPV Testing: Labcorp Rolls Out Private Self-Collection Options Nationwide - Stock Titan
Labcorp Holdings to Announce Q1 2025 Financial Results - TipRanks
Labcorp holdings EVP Amy Summy sells $175,605 in stock By Investing.com - Investing.com Canada
LabCorp EVP Mark Schroeder sells $610,450 in stock By Investing.com - Investing.com South Africa
Labcorp holdings EVP Amy Summy sells $175,605 in stock - Investing.com
LabCorp EVP Mark Schroeder sells $610,450 in stock - Investing.com
Baird Adjusts Labcorp Holdings Price Target to $292 From $293, Maintains Outperform Rating - MarketScreener
Labcorp 401(k) Plan Fee Class Action Gets Green Light for Trial - news.bloombergtax.com
Labcorp Denied Early Win In 401(k) Fee Suit - Law360
Is Labcorp Holdings Stock Outperforming the Nasdaq? - MSN
A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack - Yahoo Finance
래버러토리 코퍼레이션 (LH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
래버러토리 코퍼레이션 주식 (LH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Schroeder Mark S | EVP, Pres Diagnostics & COO |
Mar 28 '25 |
Sale |
231.67 |
2,635 |
610,450 |
4,960 |
0.41%
자본화:
|
볼륨(24시간):